| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Degradation1
Urologic Oncology Research Laboratory, Department of Urology [M. S., R. S., J. D, D. N., D. M. N.], and the Division of Hematology and Medical Oncology, Department of Medicine [J. S. G., D. M. N.], Joan and Stanford I. Weill Medical College of Cornell University, New York, New York 10021
Phorbol esters induce apoptosis in androgen-sensitive LNCaP cells, which
express neutral endopeptidase (NEP), but not in androgen-independent
prostate cancer (PC) cells, which lack NEP expression. We investigated
the role of NEP in PC cell susceptibility to
12-O-tetradecanoylphorbol-13-acetate (TPA). Western
analysis showed that expression of NEP and protein kinase C
(PKC
)
correlated with PC cell sensitivity to TPA-induced growth arrest and
apoptosis in LNCaP cells and in TSU-Pr1 cells expressing an inducible
wild-type NEP protein. Inhibition of NEP enzyme activity using the
specific NEP inhibitor CGS24592, or inhibition of PKC
using
Rottlerin at concentrations that inhibit PKC
but not PKC
,
significantly inhibited TPA-induced growth inhibition and cell death.
Furthermore, pulse-chase experiments showed PKC
is stabilized in
LNCaP cells and in TSU-Pr1 cells overexpressing wild-type NEP compared
with PC cells lacking NEP expression. This results from NEP
inactivation of its neuropeptide substrates (bombesin and
endothelin-1), which in the absence of NEP stimulate cSrc kinase
activity and induce rapid degradation of PKC
protein. These results
indicate that expression of enzymatically active NEP by PC cells is
necessary for TPA-induced apoptosis, and that NEP inhibits
neuropeptide-induced, cSrc-mediated PKC
degradation.
This article has been cited by other articles:
![]() |
J. Gong, J. Lee, H. Akio, P. N. Schlegel, and R. Shen Attenuation of Apoptosis by Chromogranin A-Induced Akt and Survivin Pathways in Prostate Cancer Cells Endocrinology, September 1, 2007; 148(9): 4489 - 4499. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Valenzuela, K. E. Pace, P. V. Cabrera, R. White, K. Porvari, H. Kaija, P. Vihko, and L. G. Baum O-Glycosylation Regulates LNCaP Prostate Cancer Cell Susceptibility to Apoptosis Induced by Galectin-1 Cancer Res., July 1, 2007; 67(13): 6155 - 6162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kajiyama, K. Shibata, M. Terauchi, T. Morita, K. Ino, S. Mizutani, and F. Kikkawa Neutral Endopeptidase 24.11/CD10 Suppresses Progressive Potential in Ovarian Carcinoma In vitro and In vivo Clin. Cancer Res., March 1, 2005; 11(5): 1798 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, N. Bennani-Baiti, and C. T. Powell Phorbol Ester-induced Apoptosis of C4-2 Cells Requires Both a Unique and a Redundant Protein Kinase C Signaling Pathway J. Biol. Chem., February 18, 2005; 280(7): 5533 - 5541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Asakuma, M. Sumitomo, T. Asano, T. Asano, and M. Hayakawa Selective Akt Inactivation and Tumor Necrosis Factor-related Apoptosis-inducing Ligand Sensitization of Renal Cancer Cells by Low Concentrations of Paclitaxel Cancer Res., March 15, 2003; 63(6): 1365 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sumitomo, M. I. Milowsky, R. Shen, D. Navarro, J. Dai, T. Asano, M. Hayakawa, and D. M. Nanus Neutral Endopeptidase Inhibits Neuropeptide-mediated Transactivation of the Insulin-like Growth Factor Receptor-Akt Cell Survival Pathway Cancer Res., April 1, 2001; 61(8): 3294 - 3298. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |